Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples

The accurate and rapid screening of serum antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the key to control the spread of 2019 coronavirus disease (COVID-19). In this study, we reported a surface-enhanced Raman scattering-based lateral flow immunoassay (SERS-LFIA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haifeng, Dai, Erhei, Xiao, Rui, Zhou, Zihui, Zhang, Minli, Bai, Zikun, Shao, Ying, Qi, Kezong, Tu, Jian, Wang, Chongwen, Wang, Shengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673228/
https://www.ncbi.nlm.nih.gov/pubmed/33230369
http://dx.doi.org/10.1016/j.snb.2020.129196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673228/
https://www.ncbi.nlm.nih.gov/pubmed/33230369
http://dx.doi.org/10.1016/j.snb.2020.129196

Ejemplares similares